News from sanofi-aventis A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 05, 2011, 01:00 ET The European Institute Honors Christine Lagarde, Managing Director of the International Monetary Fund and Dr. Elias Zerhouni, President of Global R&D, Sanofi with the Prestigious Transatlantic Leadership Award

The European Institute presented today its highest recognition, the Transatlantic Leadership Award, to Christine Lagarde, Managing Director of the...


Nov 11, 2011, 09:15 ET National Campaign Shows Veterans Why "It's Worth the Fight" Against Advanced Prostate Cancer

This Veterans Day, November 11, 2011, marks the national launch of an educational campaign designed to show veterans that "It's Worth the Fight"...


May 25, 2011, 01:05 ET Incremental innovation: essential to solving Canada's productivity problem #HNHII

Business leaders agree that encouraging incremental innovation will help Canada go from a "D" to an "A" in innovation To view the Social Media...


Apr 28, 2011, 07:30 ET sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011

Q1 2011 Change on a reported basis Change at CER(2) Change at CER(2) excluding A/H1N1 sales Net sales euro 7,779m -1.5% -5.2% +0.1% Business net...


Apr 18, 2011, 08:00 ET Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has entered into a multi-year research collaboration agreement through the...


Apr 11, 2011, 02:51 ET Time for transformational healthcare change - CEO of sanofi-aventis Canada shares thoughts on healthcare reform

To view the Social Media Release, click here: http://smr.newswire.ca/en/sanofi-aventis/time-for-transformational-healthcare-change MONTREAL, April 11 ...


Apr 08, 2011, 04:01 ET Sanofi-Aventis Completes Acquisition of Genzyme Corporation

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has completed its acquisition of Genzyme Corporation, which is now a...


Apr 04, 2011, 12:05 ET Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has successfully completed its exchange offer for all outstanding shares of...


Mar 29, 2011, 10:54 ET Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the registration statement relating to the Contingent Value Rights (CVRs) offered...


Mar 24, 2011, 08:00 ET Sanofi-aventis Enters Into Research Collaboration With Columbia University to Develop New Diabetes Treatments

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today a research collaboration with Columbia University Medical Center for the development of...


Feb 15, 2011, 08:00 ET Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot Ulcers

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Sunnybrook Health Sciences Centre (Toronto, Canada) announced that they have entered into a research ...


Feb 09, 2011, 07:30 ET sanofi-aventis: Solid Results in 2010

Q4 2010 Change on a reported basis Change at constant exchange rates 2010 Change on a reported basis Change at constant exchange rates Net sales...


Feb 09, 2011, 02:06 ET Sanofi-aventis Video Q&A: CEO Chris Viehbacher Comments on 2010 Results

Sanofi-aventis, one of the world's largest diversified healthcare companies, reports earnings for the full-year 2010. CEO Chris Viehbacher comments...


Feb 09, 2011, 02:06 ET Interview vidéo : le DG de Sanofi-aventis, Chris Viehbacher, commente les résultats 2010

Sanofi-aventis, l'un des leaders mondiaux de la santé, publie ses résultats annuels 2010. Le Directeur Général du Groupe, Chris Viehbacher, commente...


Jan 27, 2011, 04:40 ET Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its subsidiary, BiPar Sciences, today announced that a randomized Phase III trial evaluating...


Jan 25, 2011, 02:52 ET U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra® for Over-The-Counter Use

Sanofi-aventis U.S., and its U.S. Consumer Healthcare Division, Chattem, Inc., announced today that the U.S. Food and Drug Administration (FDA) has...


Jan 12, 2011, 09:00 ET Sanofi-aventis Enters Into Two Research & Development Collaborations With the University of California, San Francisco

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and the University of California, San Francisco (UCSF) announced today that they have formed two...


Jan 05, 2011, 05:00 ET Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of...


Dec 17, 2010, 10:02 ET Sanofi-aventis and Oxford University Collaborate to Conduct Oncology Research in India

Sanofi-aventis US and Oxford University have entered into an agreement to conduct multi-phase oncology clinical and epidemiological research with...


Dec 09, 2010, 09:00 ET Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the final survival analysis (10-year follow-up) of the BCIRG001 study that included ...


Nov 08, 2010, 10:42 ET Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has sent a letter to Genzyme Corporation (Nasdaq: GENZ) requesting that Genzyme...


Oct 28, 2010, 08:00 ET Resilient Sales and Business EPS(1) in Q3 2010

Q3 2010 Change on a reported basis Change at constant exchange rates 9 months 2010 Change on a reported basis Change at constant exchange rates Net...


Oct 26, 2010, 01:00 ET Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the initiation of a multinational Phase III study evaluating the efficacy and safety of...


Oct 18, 2010, 08:00 ET Sanofi-aventis Establishes Research Collaboration With Harvard University

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today a research collaboration with Harvard University. The goal of the collaboration is to...


Oct 15, 2010, 03:15 ET Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients

- Phase III TEMSO Study Meets Goals Including Delayed Disability Progression for Teriflunomide 14mg Sanofi-aventis (EURONEXT: SAN and NYSE: SNY)...